Syneos Health, Inc. – NASDAQ:SYNH

Add to watchlist

Market closed

Open in 2 days

+1.15%

month

+2.92%

quarter

-7.57%

year

Market Cap	4.45B
Enterprise value	6.91B

P/E	15.59
EV/Sales	1.28
EV/EBITDA	10.74
Price/Sales	0.76
Price/Book	1.18
PEG ratio	1.13
EPS	0.70

Revenue	5.41B
EBITDA	548.96M
Income	71.22M
Revenue Q/Q	0.39%
Revenue Y/Y	0.00%

Profit margin	4.94%
Oper. margin	7.91%
Gross margin	23.26%
EBIT margin	7.91%
EBITDA margin	10.13%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Syneos Health, Inc. (NASDAQ:SYNH): Profit margin
Sep 2022	1.33B	87.04M	6.51%
Dec 2022	1.35B	55.52M	4.08%
Mar 2023	1.35B	-72.14M	-5.32%
Jun 2023	1.36B	793K	0.06%

Syneos Health, Inc. (NASDAQ:SYNH): Earnings per share (EPS)
2022-08-02	1.19	1.25
2022-11-04	1.31	1.23
2023-02-16	1.2	1.23

Syneos Health, Inc. (NASDAQ:SYNH): Debt to assets
Sep 2022	8197783000	4.84B	59.09%
Dec 2022	8199218000	4.70B	57.37%
Mar 2023	8098776000	4.64B	57.35%
Jun 2023	8075381000	4.58B	56.74%

Syneos Health, Inc. (NASDAQ:SYNH): Cash Flow
Sep 2022	132.37M	-28.48M	-54.96M
Dec 2022	123.81M	-26.08M	-149.67M
Mar 2023	30.42M	-27.62M	199K
Jun 2023	-33.68M	-18.90M	25.94M

Syneos Health alternative data

Syneos Health
Employees

Syneos Health, Inc. (NASDAQ:SYNH): Employee count
Aug 2023	28,768
Sep 2023	28,768
Oct 2023	28,768
Nov 2023	28,768
Dec 2023	28,768
Jan 2024	28,768
Feb 2024	28,768
Mar 2024	28,768
Apr 2024	28,768
May 2024	28,768
Jun 2024	28,768
Jul 2024	28,768

Syneos Health
Hedge Funds Holdings Q3 2022

84.22% -8.49%

of SYNH is owned by hedge funds

295 -54

hedge funds hold SYNH stock

86.81M -9.99M

shares is hold by hedge funds

SYNH hedge funds holdings changes

Syneos Health, Inc. (NASDAQ:SYNH): Insider trades (number of shares)
Period	Buy	Sel
Aug 2021	0	40263
Sep 2021	0	9471
Dec 2021	0	6197
Jan 2022	0	1055
May 2022	0	200
Jul 2022	0	23703

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	28 Jul 2022	BROOKS MICHAEL LEE officer: Chief Operating Officer officer: Chief Operating Officer	Class A Common Stock	500	$78	$39,000
Sale	28 Jul 2022	BROOKS MICHAEL LEE officer: Chief Operating Officer officer: Chief Operating Officer	Class A Common Stock	1,002	$78	$78,156
Sale	21 Jul 2022	BROOKS MICHAEL LEE officer: Chief Operating Officer officer: Chief Operating Officer	Class A Common Stock	500	$76	$38,000
Sale	21 Jul 2022	BROOKS MICHAEL LEE officer: Chief Operating Officer officer: Chief Operating Officer	Class A Common Stock	1,002	$76	$76,152
Sale	20 Jul 2022	OLEFSON JONATHAN officer: General ..	Class A Common Stock	2,215	$75	$166,125
Sale	19 Jul 2022	BROOKS MICHAEL LEE officer: Chief Operating Officer officer: Chief Operating Officer	Class A Common Stock	500	$74	$37,000
Sale	19 Jul 2022	BROOKS MICHAEL LEE officer: Chief Operating Officer officer: Chief Operating Officer	Class A Common Stock	1,002	$74	$74,148
Sale	18 Jul 2022	MEGGS JASON M. officer: Chief Fi..	Class A Common Stock	7,500	$72.81	$546,075
Sale	18 Jul 2022	KEEFE MICHELLE director, officer..	Class A Common Stock	8,333	$72.81	$606,726
Sale	8 Jul 2022	KRALOWETZ DONNA HILDEBRAND officer: EVP, Chief Accounting .. officer: EVP, Chief Accounting ..	Class A Common Stock	1,149	$73.16	$84,061

Syneos Health
Earnings Call Transcripts

Quarter	Transcript
Q4 2022 16 Feb 2023	Q4 2022 Earnings Call Transcript
Q3 2022 4 Nov 2022	Q3 2022 Earnings Call Transcript
Q2 2022 2 Aug 2022	Q2 2022 Earnings Call Transcript
Q1 2022 29 Apr 2022	Q1 2022 Earnings Call Transcript

SYNH earnings call transcripts

Syneos Health
Executives

Insider	Age	Compensation
Mr. Alistair Macdonald (1970) Chief Executive Officer & Director	55	$1,680,000
Mr. Jason M. Meggs (1976) Chief Financial Officer	49	$766,130
Mr. Paul D. Colvin (1970) Chief Bus. Officer	55	$728,810
Ms. Michelle Keefe (1967) Pres of Commercial Solutions	58	$728,530
Mr. Jonathan Olefson (1976) Gen. Counsel & Corporation Sec.	49	$559,570

Syneos Health
Latest News

Wednesday, 9 October 2024
09:00	Syneos Health Appoints Costa Panagos as Chief Executive Officer	globenewswire.com
Thursday, 4 January 2024
12:00	Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®	globenewswire.com
Wednesday, 13 September 2023
09:46	Syneos Health (SYNH) Declares Strategic Partnership With Oracle	Zacks Investment Research
Tuesday, 25 July 2023
11:38	Earnings Preview: Syneos Health (SYNH) Q2 Earnings Expected to Decline	Zacks Investment Research
Tuesday, 27 June 2023
09:03	Syneos Health (SYNH) Collaborates With uMotif for New Platform	Zacks Investment Research
Wednesday, 7 June 2023
14:34	Syneos Health (SYNH) Sell-Off Appears Strategic Amid Margin Woes	Zacks Investment Research
Thursday, 11 May 2023
10:39	Syneos Health (SYNH) Announces a $7.1 Billion Merger Agreement	Zacks Investment Research
Wednesday, 10 May 2023
09:55	Syneos Health (SYNH) Q1 Earnings and Revenues Surpass Estimates	Zacks Investment Research
09:29	SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today	InvestorPlace
08:02	Syneos Health Stock Rises on $7.1 Billion Sale to Private Group	Barrons
Tuesday, 9 May 2023
16:40	Syneos Health's stock soars 19% on acquisition report	Market Watch
Monday, 8 May 2023
09:54	Here's Why Investors Should Retain Syneos Health (SYNH) for Now	Zacks Investment Research
Monday, 1 May 2023
13:10	CashFlow Hunter On Catalyst Hedge Investing, Coinbase, 3M, Schwab And UBS	Seeking Alpha
Thursday, 13 April 2023
16:31	Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023	GlobeNewsWire
Wednesday, 12 April 2023
17:19	Syneos Health: Rumors Of Private Equity Circling, Potential 40% Upside	Seeking Alpha
Friday, 24 March 2023
14:28	MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare	Zacks Investment Research
Thursday, 23 March 2023
09:54	Syneos Health (SYNH) Partners With KX for Data-Driven Insights	Zacks Investment Research
Tuesday, 21 March 2023
10:43	Syneos Health's (SYNH) New Microsoft Deal to Expand AI Usage	Zacks Investment Research
Wednesday, 15 March 2023
12:14	Syneos Health's (SYNH) Product Launch Aids, FX Woe Hurts	Zacks Investment Research
Friday, 17 February 2023
12:02	Syneos Health (SYNH) Q4 Earnings Beat Estimates, Margins Down	Zacks Investment Research
Thursday, 16 February 2023
12:34	Syneos Health, Inc. (SYNH) Q4 2022 Earnings Call Transcript	Seeking Alpha
09:02	Syneos Health (SYNH) Tops Q4 Earnings and Revenue Estimates	Zacks Investment Research
Wednesday, 8 February 2023
21:41	Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023	GlobeNewsWire
Thursday, 26 January 2023
12:02	Syneos Health (SYNH) Signs New Partnership With Cryoport	Zacks Investment Research
Thursday, 12 January 2023
10:32	Syneos Health (SYNH) to Launch Serplulimab With New Pact	Zacks Investment Research
Tuesday, 3 January 2023
16:31	Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference	GlobeNewsWire
Friday, 30 December 2022
11:17	Syneos Health (SYNH) Hurt by Low Reimbursable Expense, FX Issue	Zacks Investment Research
Friday, 4 November 2022
11:58	Syneos Health, Inc. (SYNH) Q3 2022 Earnings Call Transcript	Seeking Alpha
Friday, 21 October 2022
16:30	Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022	GlobeNewsWire
Tuesday, 13 September 2022
12:47	Here's Why Investors Should Retain Syneos Health (SYNH) for Now	Zacks Investment Research

Ideas & Opinions

Seeking Alpha 12 Apr 2023

Syneos Health: Rumors Of Private Equity Circling, Potential 40% Upside
Seeking Alpha 3 Jan 2023

Idorsia: The Foundation Is In Place And The Co. Is Ready For Great Success In 2023
Seeking Alpha 2 Aug 2022

Syneos Health, Inc. 2022 Q2 - Results - Earnings Call Presentation
Seeking Alpha 15 Jul 2022

Syneos: Upside Could Be Priced In, Valuations Unsupportive
Seeking Alpha 29 Apr 2022

IQVIA A Smart Choice In A High-Inflation Environment
Seeking Alpha 29 Apr 2022

Syneos Health, Inc. 2022 Q1 - Results - Earnings Call Presentation
Seeking Alpha 9 Apr 2022

Medpace Holdings: Recent Price Dislocation Buying Opportunity
Seeking Alpha 27 Mar 2022

Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Seeking Alpha 18 Feb 2022

Syneos Health, Inc. 2021 Q4 - Results - Earnings Call Presentation
Seeking Alpha 21 Jan 2022

Idorsia: Heading Towards Profitability Faster Than Expected

Frequently Asked Questions (FAQ)

When is Syneos Health's next earnings date?

Unfortunately, Syneos Health's (SYNH) next earnings date is currently unknown.
Does Syneos Health pay dividends?

No, Syneos Health does not pay dividends.
How much money does Syneos Health make?

Syneos Health has a market capitalization of 4.45B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.46% to 5.39B US dollars. Syneos Health earned 266.5M US dollars in net income (profit) last year or $1.23 on an earnings per share basis.
What is Syneos Health's stock symbol?

Syneos Health, Inc. is traded on the NASDAQ under the ticker symbol "SYNH".
What is Syneos Health's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of Syneos Health?

Shares of Syneos Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Syneos Health's key executives?
Syneos Health's management team includes the following people:
- Mr. Alistair Macdonald Chief Executive Officer & Director(age: 55, pay: $1,680,000)
- Mr. Jason M. Meggs Chief Financial Officer(age: 49, pay: $766,130)
- Mr. Paul D. Colvin Chief Bus. Officer(age: 55, pay: $728,810)
- Ms. Michelle Keefe Pres of Commercial Solutions(age: 58, pay: $728,530)
- Mr. Jonathan Olefson Gen. Counsel & Corporation Sec.(age: 49, pay: $559,570)
How many employees does Syneos Health have?

As Jul 2024, Syneos Health employs 28,768 workers.
When Syneos Health went public?

Syneos Health, Inc. is publicly traded company for more then 10 years since IPO on 7 Nov 2014.
What is Syneos Health's official website?

The official website for Syneos Health is syneoshealth.com.
Where are Syneos Health's headquarters?

Syneos Health is headquartered at 1030 Sync Street, Morrisville, NC.
How can i contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville, NC and company can be reached via phone at +91 98769300.

Syneos Health, Inc.

syneoshealth.com

Exchange:

NASDAQ

Full time employees:

28,768

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

+91 98769300

1030 Sync Street
Morrisville, NC 27560-5468

CIK: 0001610950
ISIN: US87166B1026
CUSIP: 87166B102